Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125492711 | 12549271 | 1 | I | 20150202 | 20160629 | 20160712 | 20160712 | EXP | US-CELGENEUS-USA-2016067146 | CELGENE | 83.00 | YR | M | Y | 82.18000 | KG | 20160712 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125492711 | 12549271 | 1 | PS | REVLIMID | LENALIDOMIDE | 1 | Oral | Y | U | 21880 | 10 | MG | CAPSULES | ||||||
| 125492711 | 12549271 | 2 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | Y | U | 21880 | 10 | MG | CAPSULES | ||||||
| 125492711 | 12549271 | 3 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | U | 21880 | 100 | MG/M**2 | UNKNOWN | |||||||
| 125492711 | 12549271 | 4 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | U | 21880 | 100 | MG/M**2 | UNKNOWN | |||||||
| 125492711 | 12549271 | 5 | SS | Rituximab | RITUXIMAB | 1 | Intravenous drip | U | 21880 | 375 | MG/M**2 | INJECTION | |||||||
| 125492711 | 12549271 | 6 | SS | Rituximab | RITUXIMAB | 1 | Intravenous drip | U | 21880 | 375 | MG/M**2 | INJECTION | |||||||
| 125492711 | 12549271 | 7 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous drip | U | 21880 | 750 | MG/M**2 | INJECTION | |||||||
| 125492711 | 12549271 | 8 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous drip | U | 21880 | 750 | MG/M**2 | INJECTION | |||||||
| 125492711 | 12549271 | 9 | SS | Doxorubicin | DOXORUBICIN | 1 | Intravenous drip | U | 21880 | 50 | MG/M**2 | INJECTION | |||||||
| 125492711 | 12549271 | 10 | SS | Doxorubicin | DOXORUBICIN | 1 | Intravenous drip | U | 21880 | 50 | MG/M**2 | INJECTION | |||||||
| 125492711 | 12549271 | 11 | SS | Vincristine | VINCRISTINE | 1 | Intravenous drip | U | 21880 | 1.4 | MG/M**2 | INJECTION | |||||||
| 125492711 | 12549271 | 12 | SS | Vincristine | VINCRISTINE | 1 | Intravenous drip | U | 21880 | 1.4 | MG/M**2 | INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125492711 | 12549271 | 1 | Diffuse large B-cell lymphoma |
| 125492711 | 12549271 | 3 | Diffuse large B-cell lymphoma |
| 125492711 | 12549271 | 5 | Diffuse large B-cell lymphoma |
| 125492711 | 12549271 | 7 | Diffuse large B-cell lymphoma |
| 125492711 | 12549271 | 9 | Diffuse large B-cell lymphoma |
| 125492711 | 12549271 | 11 | Diffuse large B-cell lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125492711 | 12549271 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125492711 | 12549271 | Mental status changes | |
| 125492711 | 12549271 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125492711 | 12549271 | 1 | 20141029 | 0 | ||
| 125492711 | 12549271 | 2 | 20150128 | 20150201 | 0 | |
| 125492711 | 12549271 | 3 | 20141029 | 0 | ||
| 125492711 | 12549271 | 4 | 20150128 | 20150201 | 0 | |
| 125492711 | 12549271 | 5 | 20141029 | 0 | ||
| 125492711 | 12549271 | 6 | 20150128 | 20150128 | 0 | |
| 125492711 | 12549271 | 7 | 20141029 | 0 | ||
| 125492711 | 12549271 | 8 | 20150128 | 20150128 | 0 | |
| 125492711 | 12549271 | 9 | 20141029 | 0 | ||
| 125492711 | 12549271 | 10 | 20150128 | 20150128 | 0 | |
| 125492711 | 12549271 | 11 | 20141029 | 0 | ||
| 125492711 | 12549271 | 12 | 20150128 | 20150128 | 0 |